People with MS in Denmark grew older from 1950 to 2023

Credibility

Interest

Share:2 min read

Key Takeaway

The average age of people with MS in Denmark rose modestly, while women became a larger share of the MS population.

What They Found

The average age rose to about 53 by the late 1970s, then stayed fairly steady until 1990. It dipped to about 51 in 2005 before reaching about 54 in 2023. Women made up about 59% of people with MS in 1975 and about 69% in 2023. The rate of new MS diagnoses rose more than threefold between 1975 and 2000. That rate was fairly steady after 2000, while the number of people living with MS continued to rise.

Who Should Care and Why

The study included people with confirmed MS who lived in Denmark between 1950 and 2023. It describes changes in the Danish MS population, rather than changes in one person's MS. People interested in aging with MS may note that the average age rose, but not as much as researchers expected. The growing share of women is another change in who was living with MS. The findings give researchers a record of Danish MS trends to compare with future studies.

Important Considerations

Researchers examined national records for 28,145 people with MS; they did not test a treatment. The records show population trends, but this study does not establish what caused them. Because the study covered Denmark, you cannot assume the same trends occurred elsewhere.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Living with MS

Article Topics:

changedemographicsdevelopmentepidemiologyhistorical fluctuationsprospectively collected data

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News